MENU
+Compare
TFX
Stock ticker: NYSE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$103.04
Change
-$0.86 (-0.83%)
Capitalization
4.59B

TFX Teleflex Forecast, Technical & Fundamental Analysis

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas... Show more

TFX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TFX with price predictions
Jan 13, 2026

TFX's RSI Oscillator is sitting in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

TFX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TFX as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TFX turned negative on December 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

TFX moved below its 50-day moving average on January 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TFX crossed bearishly below the 50-day moving average on January 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TFX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TFX entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.201) is normal, around the industry mean (11.802). P/E Ratio (29.079) is within average values for comparable stocks, (168.298). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (2.531). Dividend Yield (0.013) settles around the average of (0.017) among similar stocks. P/S Ratio (1.473) is also within normal values, averaging (113.639).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TFX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
TFX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TFX is expected to report earnings to rise 4.09% to $3.82 per share on February 19

Teleflex TFX Stock Earnings Reports
Q4'25
Est.
$3.82
Q3'25
Beat
by $0.29
Q2'25
Beat
by $0.37
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.03
The last earnings report on November 06 showed earnings per share of $3.67, beating the estimate of $3.38. With 285.29K shares outstanding, the current market capitalization sits at 4.59B.
A.I.Advisor
published Dividends

TFX paid dividends on September 15, 2025

Teleflex TFX Stock Dividends
А dividend of $0.34 per share was paid with a record date of September 15, 2025, and an ex-dividend date of August 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of medical devices for critical care, urology and surgery

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
550 East Swedesford Road
Phone
+1 610 225-6800
Employees
14500
Web
https://www.teleflex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMMX20.800.01
+0.05%
Invesco Summit C
AZBCX22.32-0.03
-0.13%
Virtus Small-Cap C
GSINX22.45-0.05
-0.22%
Goldman Sachs GQG Ptnrs Intl Opps Inv
WILNX22.78-0.05
-0.22%
William Blair International Ldrs N
HNCUX23.30-0.21
-0.89%
Hartford International Growth R6

TFX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with XRAY. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-4.29%
XRAY - TFX
56%
Loosely correlated
-2.96%
A - TFX
51%
Loosely correlated
-1.13%
RVTY - TFX
47%
Loosely correlated
+6.02%
AZTA - TFX
45%
Loosely correlated
+2.56%
TNDM - TFX
44%
Loosely correlated
-2.11%
More

Groups containing TFX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-4.29%
Pharmaceuticals: Other
industry (106 stocks)
47%
Loosely correlated
-0.12%
Pharmaceuticals
industry (383 stocks)
44%
Loosely correlated
+0.10%